Vaping Could Increase Risk Of Cancer, But It's Still Hazy

The long and short of it is that vaping might increase the risk of cancer, although it’s safer than smoking tobacco. hurricanehank/Shutterstock

A new piece of research weighs in on the hot topic of vaping and its effect on health, specifically looking at the effect of e-cigarette vapor and DNA mutations that may eventually lead to cancer.

The long and short of it is that vaping with nicotine might increase the risk of cancer, although it’s safer than smoking tobacco.

As explained in the journal Proceedings of the National Academy of Sciences, scientists at the New York University School of Medicine exposed laboratory mice to the different components of e-cigarette vapor, both nicotine and harmless organic solvents.

The results showed that vapor damages DNA and reduces DNA repair activity in the lung, heart, and bladder of mice. Perhaps unsurprisingly though, it’s the nicotine that causes the damage, while solvents themselves do not appear to cause DNA damage at all. It’s also important to remember that when you smoke a conventional cigarette, you are inhaling this nicotine along with a lethal cocktail of carbon monoxide and at least 70 known cancer-causing chemicals.

For another part of the experiment, the scientists exposed cultured human cells to large quantities of nicotine in a lab and found similar effects on DNA damage and repair. However, the researchers also cited another study that found 97 percent less of a key biomarker related to genetic damage in the urine of vaper smokers compared with smokers. Basically, this means that nicotine increases cancer risk in theory, but in practice it's not quite as clear or simple as that.

Some experts not involved in the study aren’t so enthusiastic about the findings. Professor Peter Hajek, director of the Tobacco Dependence Research Unit at Queen Mary University of London, believes that these results add nothing new to the debate on e-cigs and health.  

Full Article

If you liked this story, you'll love these

This website uses cookies

This website uses cookies to improve user experience. By continuing to use our website you consent to all cookies in accordance with our cookie policy.